Evidence map›Paper›PMID 28838168›Full record

ArticleThe Journal of infectious diseases2017

Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine.

Sarah Wanyoike, Alejandro Ramirez Gonzalez, Samantha B Dolan, Julie Garon, Chantal Laroche Veira, Lee M Hampton, Diana Chang Blanc, Manish M Patel

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sarah WanyoikeTask Force for Global Health, Atlanta, Georgia.
Alejandro Ramirez GonzalezWorld Health Organization, Geneva, Switzerland.
Samantha B DolanGlobal Immunization Division, Center for Global Health, Centers for Disease Control and Prevention.
Julie GaronDivision of Infectious Diseases, Emory University School of Medicine.
Chantal Laroche VeiraTask Force for Global Health, Atlanta, Georgia.
Lee M HamptonGlobal Immunization Division, Center for Global Health, Centers for Disease Control and Prevention.
Diana Chang BlancWorld Health Organization, Geneva, Switzerland.
Manish M PatelTask Force for Global Health, Atlanta, Georgia.
The Task Force for Global Health · USCenter for Global Health · USWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

Until recently, waste management for national immunization programs was limited to sharps waste, empty vaccine vials, or vaccines that had expired or were no longer usable. However, because wild-type 2 poliovirus has been eradicated, the World Health Organization's (WHO's) Strategic Advisory Group of Experts on Immunization deemed that all countries must simultaneously cease use of the type 2 oral polio vaccine and recommended that all countries and territories using oral polio vaccine (OPV) "switch" from trivalent OPV (tOPV; types 1, 2, and 3 polioviruses) to bivalent OPV (bOPV; types 1 and 3 polioviruses) during a 2-week period in April 2016. Use of tOPV after the switch would risk outbreaks of paralysis related to type 2-circulating vaccine-derived poliovirus (cVDPV2). To minimize risk of vaccine-derived polio countries using OPV were asked to dispose of all usable, unexpired tOPV after the switch to bOPV. In this paper, we review the rationale for tOPV disposal and describe the global guidelines provided to countries for the safe and appropriate disposal of tOPV. These guidelines gave countries flexibility in implementing this important task within the confines of their national regulations, capacities, and resources. Steps for appropriate disposal of tOPV included removal of all tOPV vials from the cold chain, placement in appropriate bags or containers, and disposal using a recommended approach (ie, autoclaving, boiling, chemical inactivation, incineration, or encapsulation) followed by burial or transportation to a designated waste facility. This experience with disposal of tOPV highlights the adaptability of national immunization programs to new procedures, and identifies gaps in waste management policies and strategies with regard to disposal of unused vaccines. The experience also provides a framework for future policies and for developing programmatic guidance for the ultimate disposal of all OPV after the eradication of polio.

Indexed as

Poliovirus Vaccine, OralWaste ManagementHumansMedical Waste DisposalPoliomyelitisSterilizationMedical Waste DisposalPoliovirus Vaccine, OraldisposalOPVoral polio vaccinepoliopolioviruswaste management

Identifiers

PMID28838168
PMCPMC5853297
OpenAlexW2736030423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.